Reverse Transcriptase Inhibitors for Oxidative Stress DNA Damage

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Degenerative diseases, particularly neurodegenerative diseases like Parkinson's and Alzheimer's, are exacerbated by oxidative stress that induces DNA double-strand breaks and the expression of transposable elements, leading to cellular damage and aging.

Innovation Solution

Utilizing reverse transcriptase inhibitors, such as nucleoside inhibitors like Stavudine, to reduce DNA double-strand break formation and suppress the expression of transposable elements, thereby mitigating oxidative stress-induced damage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Temperature

If oxidative stress increases (mimicking accelerated aging), then reactive oxygen species generation increases, but DNA double-strand breaks and transposable element expression increase leading to cellular damage

Engineering Contradiction:

Improveoxidative stress levelVSAvoidDNA double-strand breaks

Core Design Contradiction:

TemperatureVSObject-affected harmful factors

Solution Approach 1:

The patent applies reverse transcriptase inhibitors to convert the harmful effect of oxidative stress-induced transposable element expression into a beneficial outcome by blocking the reverse transcription process, thereby preventing DNA double-strand breaks while maintaining the oxidative stress response as a detectable marker of disease progression

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

2Reliability

If reverse transcriptase inhibitors are used to reduce DNA double-strand breaks, then transposable element expression is suppressed, but the mechanism of action involves inhibiting reverse transcription process

Engineering Contradiction:

ImproveDNA integrityVSAvoidinhibitor mechanism complexity

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent uses reverse transcriptase inhibitors as intermediary substances that mediate between oxidative stress and DNA damage by blocking the reverse transcription of transposable elements, thereby protecting genomic integrity without directly interfering with oxidative stress pathways

Inventive Principle:

Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of reverse transcriptase inhibitors effectively decreases DNA double-strand breaks and heterochromatin disruption, reducing the progression of degenerative diseases and neuronal cell death.

Implementation Method 1

ORF2 encodes a reverse transcriptase (RT) that copies the LINE RNA into DNA... the inventors showed that oxidative stress induces the formation of DNA double-strand breaks, heterochromatin disruption, and the expression of transposable element (LINE) genes. They proposed that oxidative stress-induced LINE expression is at least partly responsible for DSB formation and demonstrated that DSB formation is reduced in the presence of a reverse transcriptase inhibitor.

Methodology Applied

Scientific EffectReverse transcriptase inhibition: Enzyme

Data Source

PatentEP3212200B2Use of an inverse transcriptase inhibitor for the treatment and prevention of degenerative diseases

Publication Date: 2025.12.24 COLLEGE DE FRANCE

Figure 1A~1E
Figure 2A~2B
Figure 3A~3B

AI summary

The invention relates to the use of a reverse-transcriptase inhibitor in the prevention or treatment of a degenerative disease.